Academia.eduAcademia.edu
Vol. 10(25), pp. 360-366, 3 July, 2016 DOI: 10.5897/JMPR2016.6122 Article Number: 17DDCEC59276 ISSN 1996-0875 Copyright © 2016 Author(s) retain the copyright of this article http://www.academicjournals.org/JMPR Journal of Medicinal Plants Research Full Length Research Paper Modulatory effects of Hilleria latifolia and Laportea ovalifolia on activity of selected antibiotics Susana Oteng Dapaah, Christian Agyare*, Yaw Duah Boakye and Theresa Appiah Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. Received 13 April, 2016; Accepted 9 June, 2016 Microorganisms are becoming resistant to almost all existing and newly discovered antimicrobial agents. This has led to ineffective treatment of infectious diseases with increased risk of complications. Few medicinal plants have been found to exhibit the ability of reversing the resistance mechanisms of microbes to antibiotics. The study investigates the influence of leaf methanol extracts of Hilleria latifolia and Laportea ovalifolia on some commonly used antibiotics. Micro-dilution technique was used to determine the antimicrobial activity and minimum inhibitory concentration (MIC) of the leaf extracts and the selected antibiotics. MICs of the antibiotics in presence of sub-inhibitory concentration of the extracts were determined. MIC of H. latifolia and L. ovalifolia extracts ranged from 50 to 100 mg/ml. In the presence of sub-inhibitory concentration (5 mg/ml) of the extracts, the activity of the antibiotics was modified with enhanced or reduced activity. The activity of amoxicillin was potentiated by 8-folds, 4folds, 2-folds, 8-folds, and 2-folds against Escherichia coli, Bacillus subtilis, Salmonella typhi, Staphylococcus aureus and Pseudomonas aeruginosa, respectively in the presence of leaf extract of H. latifolia. Activity of ampicillin was potentiated by 2- and 4-folds against E. coli and S. typhi, respectively, as well as tetracycline, 4-folds, against Klebsiella pneumonia in the presence of leaf extract of H. latifolia. Sub-inhibitory concentrations of H. latifolia and L. ovalifolia extracts reduced the activities of erythromycin and ciprofloxacin against all the test organisms. Sub-inhibitory concentrations of H. latifolia and L. ovalifolia extracts modified the activities of the selected antibiotics. Key words: Minimum inhibitory concentration, antibiotics, microbial resistance, antibiotic-resistance modifying agents. INTRODUCTION Pathogenic organisms which were previously known to have been killed or inhibited by antibiotics are now resistant to these same antimicrobial agents (Levy and Marshall, 2004). This has forced a number of pharmaceutical companies to leave the field of antibiotic discovery and production to rather produce more profitable medications for treating other diseases especially non-communicable diseases (Projan, 2003). The problem of resistance is now posing great threat on public health more than ever before, due to increasing *Corresponding author. E-mail: cagyare.pharm@knust.edu.gh or chrisagyare@yahoo.com. Tel: +233246369803. Author(s) agree that this article remain permanently open access under the terms of the Creative Commons Attribution License 4.0 International License Dapaah et al. multi-drug resistance in a single organism drastically limiting therapeutic options (Levy, 2005). Naturally, bacteria have the ability to genetically develop resistance to antibacterial agents (Nascimento et al., 2000). They use different ways and strategies to acquire or develop resistance to antibiotics, which include, active efflux of drugs, alteration of target sites and inactivation of antibiotics by producing enzymes that degrade them (Sibanda and Okoh, 2007). Also, inappropriate diagnosis, drug counterfeit, use of antibiotics in food production and animal rearing, noncompliance and under dosing and sometimes uncontrolled use of antimicrobial agents are factors that contribute greatly to the overwhelming increase in the microbial resistant menace in this generation (Adu et al., 2014). Microbial resistance to antimicrobial agents has limited the use of known cheap but effective antibiotics (Ranjan et al., 2012). This has necessitated the search for new potent antimicrobial agents to combat the threat posed by resistant microbes. In search of antimicrobial agents, various sources such as the synthetic compounds as well as bioactive agents from natural products (aquatic microorganisms and medicinal plants) are taken into consideration (Agyare et al., 2012). Medicinal plants are great sources of antimicrobial agents and the idea that plants have been used as effective drugs for treatment of infectious diseases was well accepted even before the discovery of microbes (Rios and Recio, 2005). Coates et al. (2002) reported the occurrence of cross resistance to newly identified antibiotics and other antimicrobial agents suggesting that newly discovered antimicrobial agents may be rendered ineffective in the near future. Even though the appropriate use of these antimicrobial agents can reduce the rate of resistance development, it cannot eliminate the emergence of resistant strains (Sibanda and Okoh, 2007). There is therefore the need to discover and develop new compounds that will target and block resistance mechanisms to help treat infections from these resistant strains (Oluwatuyi et al., 2004). Medicinal plants have been found to contain compounds with or without antimicrobial property that can cause resistant microorganisms to be susceptible to a previously impotent antibiotic (Aiyegoro et al., 2009). In most developing countries, where majority of the people rely on medicinal plants and natural products, they combine their orthodox medications with these plants in the treatment of various diseases (Adu et al., 2014; Agyare et al., 2009). This study, therefore, investigates the influence of leaf methanol extracts of Hilleria latifolia and Laportea ovalifolia on some commonly used antibiotics. H. latifolia (Lam.) H. Walt belongs to the family Phytolaccaceae and is locally known by the Ewes as ‘avegboma’ and ‘anafranaku’ by the Asantes in Ghana. It is a perennial herb of 30 to 120 cm high, with ovate-elliptic leaves and numerous short hair-like 361 structures on lower surface. The leaves are used in Ghana for the management of rheumatism, boils and wounds (Agyare et al., 2009). The leaves are used to treat general oedema, asthma and some skin diseases (Mshana, 2000; Dokosi, 1998). It is also used to treat cough with blood (Schmelzer and Gurib-Fakim, 2008). L. ovalifolia (Schumach.) Chew belongs to the family Urticaceae. It is known by the Asantes in Ghana as ‘akyekyenwonsa’, ‘abrewa nom taa’ or ‘Kumasi otuo’. It is a herbaceous weed more often creeping than erect and densely covered with stinging hairs (Chew, 1969). L. ovalifolia is of two varieties, that is, male and female (Essiett et al., 2011). Leaves are used to treat wounds (Agyare et al., 2009) and the fruits are used as a poison antidote (Bouch, 2004). The root extract is used to prevent or reduce excessive menstrual bleeding (Sofowora, 1996).. MATERIALS AND METHODS Plant collection Leaves of H. latifolia and L. ovalifolia were collected from Aburi in the Eastern region of Ghana on February, 2014. The plants were authenticated by Dr. Alex Asase of the Department of Botany, University of Ghana, and voucher specimen AA 63 and AA 71, respectively deposited in the Ghana Herbarium, Department of Botany, University of Ghana, Legon, Accra, Ghana. Plant extraction The fresh leaves collected were washed thoroughly under running tap-water and dried under shade between 25 and 28°C for two weeks, after which they were pulverized into coarse powder using the laboratory milling machine (Christy and Norris, Chelmsford, England). 800 g each of the powdered plant materials were soaked in 2.5 L of 70% v/v methanol. They were extracted with the aid of ultra-turrax (T 25 Janke and Kunkel, Labortenik, Germany) under ice-cooling at a speed of 24000 rpm for 3 to 5 min, and then filtered using a laboratory sieve (Retsch, Haan, Germany) of mesh number 200 with aperture of 75 μm and Whatmann filter paper No.1. The filtrates were concentrated with the rotary evaporator (Rotavapor BÜCHI R-200 with heating bath B-490, Büchi, Konstanz) at 40°C under reduced pressure and lyophilized and then stored in air tight containers at 4 to 8°C. The yields of the extracts of H. latifolia and L. ovalifolia were 17.4 and 11.29% w/w, related to the dried material, respectively. Preliminary phytochemical screening Methanol leaf extracts of H. latifolia (HLLE) and L. ovalifolia (LOLE) and their respective powdered dried plant materials were subjected to qualitative phytochemical analysis to identify various secondary metabolites such as tannins, glycosides, saponins, alkaloids, flavonoids, steroids and terpenoids present using standard methods described by Usman et al. (2014), Trease and Evans (2002) and Sofowora (1993). High performance liquid chromatography (HPLC) profile of extracts HPLC analysis was performed to identify the profile or finger-prints 362 J. Med. Plants Res. Table 1. Phytochemical screening of methanol leaf extracts of H. latifolia and L. ovalifolia, and their dried powdered plant materials. Secondary metabolites Tannins Flavonoids Glycosides Saponin Alkaloids Sterols Terpenoids HLLE + + + + + + + H. latifolia leaf Powdered plant material + + + + + + + LOLE + + + + L. ovalifolia leaf Powdered plant material + + + + + (+) = Presence of secondary metabolites; (-) = absence of secondary metabolites. HLLE: Methanol leaf extract of H. latifolia; LOLE: methanol leaf extract of L. ovalifolia. of the crude extracts with a UV-detector set at a wavelength of 254 nm. The running conditions included injection volume of 10 μl, mobile phase of methanol:water (20:80 v/v, isocratic condition), flow rate of 1 ml/min and pressure of 15 MPa. The chromatographic data were determined using Chrom Quest® software. Test organisms Test organisms were obtained from the microbiology laboratory of the Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana. They include Pseudomonas aeruginosa ATCC 4853, Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 25923, Bacillus subtilis NCTC 10073, Enterococcus faecalis ATCC 29212 and clinical strains of Streptococcus pyogenes, Salmonella typhi and Klebsiella pneumonia. They were stored in 30% glycerol broth at -4°C in a frost free freezer (Mistral, UK) until needed, whereby 100 μl of the stock suspension was transferred into 10 ml nutrient broth (Oxoid Limited, United Kingdom) and incubated at 37°C for 24 h (subcultured) before use. Determination of antibacterial activity and minimum inhibitory concentration (MIC) of extracts Micro-dilution method described by Eloff (1998) and modified by Agyare et al. (2012) was used to determine the antibacterial activity and the MIC of the extracts. Each well of micro-titre plate (96 wells) was filled with 100 μl of double strength nutrient broth, 20 μl of 106 cfu/ml of the test organisms and 80 μl of different concentrations of HLLE and LOLE ranging from 1.56 to 100 mg/ml. Ciprofloxacin (Sigma-Aldrich, Michigan, USA) at concentration range of 1.0 to 128 μg/ml was used as reference antibiotic drug. Control wells were filled with broth only and broth and test organisms only. After 24 h of incubation at 37°C, 20 µl of 1.25 mg/ml of 3-(4, 5-dimethylthiazol2-yl)-2, 5-diphenyltetrazolium bromide (MTT) (Sigma-Aldrich, Taufkirchen, Germany) was added to each well and observed for a purple colouration after incubation at 37°C for 30 min which indicated microbial growth. The minimum concentrations of HLLE, LOLE and reference drug that did not show any colour change in the wells were recorded as the MIC. The method was replicated three times to validate the results. concentration of the extracts on the activity of some selected antibiotics including amoxicillin, erythromycin, ciprofloxacin, tetracycline and ampicillin (Sigma-Aldrich, Michigan, USA). The micro-dilution technique with some modifications as described by Adu et al. (2014) was employed. The MICs of the antibiotics were first determined using concentrations ranging from 1 to 1024 μg/ml. Each of the 96 wells of the micro-titre plate was filled with 100 μl of double strength nutrient broth, appropriate volume of different concentrations of the antibiotics and 20 μl of 106 cfu/ml of the test organisms. The plate was incubated for 24 h at 37°C, after which 20 μl MTT was added to the wells and MIC determined as the lowest concentration at which no growth was observed (that is, no colour change from yellow to purple). MICs of the antibiotics were re-determined in the presence of sub-inhibitory concentration (5 mg/ml) of the extracts (HLLE and LOLE). RESULTS Various phytochemical tests were performed on HLLE and LOLE and their dried powdered plant materials to identify their phytochemical composition. Phytochemical screening of HLLE and dried powdered leaf material of H. latifolia revealed the presence of tannins, flavonoids, glycosides, saponins, alkaloids, sterols and terpenoids. LOLE and the pulverized leaf material of L. ovalifolia also showed the presence of tannins, glycosides, sterols and terpenoids. However, saponins was found in the powdered leaf material of L. ovalifolia but was absent in its extract (Table 1). HPLC profiles of extracts Chemical profiles of the extracts indicate the present of metabolites/compounds at the wavelength used and these will serve as a guide in identifying the plants (Figures 1 and 2). Antibacterial activity and MIC of extracts Microbial resistance modifying activity of the extracts This study was done to determine the effect of a sub-inhibitory MICs of HLLE and LOLE against typed and clinical strains of organisms, consisting of Gram-positive bacteria Dapaah et al. 363 Table 2. MIC of methanol leaf extracts of H. latifolia and L. ovalifolia against test organisms. Test organisms B. subtilis S. aureus E. feacalis S. pyogenes E. coli S. typhi K. pneumoniae P. aeruginosa MIC of extracts and reference drug HLLE (mg/ml) LOLE (mg/ml) Cip (μg/ml) 50.0 50.0 2.0 50.0 100.0 4.0 50.0 100.0 4.0 50.0 100.0 4.0 50.0 100.0 2.0 50.0 50.0 4.0 50.0 50.0 4.0 50.0 50.0 4.0 HLLE: Methanol leaf extract of H. latifolia; LOLE: methanol leaf extract of L. ovalifolia; Cip: Ciprofloxacin. (B. subtilis, S. aureus, E. feacalis, S. pyogenes) and Gram-negative bacteria (E. coli, S. typhi, K. pneumonia, P. aeruginosa) were between 50 and 100 mg/ml (Table 2). Antibiotic modulatory activity of methanol leaf extracts of H. latifolia (HLLE) and L. ovalifolia (LOLE) Activities of the selected antibiotics (amoxicillin, erythromycin, ciprofloxacin, tetracycline and ampicillin) against the test microorganisms were modified in the presence of sub-inhibitory concentration (5 mg/ml) of the extracts, either by enhanced or reduced activity. For instance, the activity of amoxicillin against E. coli, B. subtilis, S. typhi, S. aureus and P. aeruginosa potentiated by 8-, 4-, 2-, 8- and 2-folds, respectively, in the presence of the sub-inhibitory concentration of HLLE. Sub-inhibitory concentration of HLLE again enhanced the activity of ampicillin 2- and 4-folds against E. coli and S. typhi, respectively, as well as tetracycline, 4 folds, against K. pneumonia. The activity of amoxicillin against S. aureus and E. coli was enhanced (2-folds) in the presence of LOLE. However, both HLLE and LOLE sub-inhibitory concentrations reduced the activities of erythromycin and ciprofloxacin against all test organisms (Table 3). DISCUSSION Secondary metabolites such as tannins, flavonoids, glycosides, alkaloids, terpenoids and steroids present in the plants may be responsible for their pharmacological and biological properties (Maganha et al., 2010; BarbosaFilho et al., 2006; Mbagwu et al., 2007; Sofowora, 1993). These secondary metabolites act alone or in synergy leading to the healing potentials of plants (Jenke-Kodama et al., 2008; Gurib-Fakim, 2006). Phytochemical screening of plant materials revealed the presence of tannins, glycosides, saponins, flavonoids, alkaloids, sterols and terpenoids in the leaves of H. latifolia, which is similar to reports on the same plant by Abotsi et al. (2012) and Schmelzer and Gurib-Fakim (2008). Tannins, glycosides, sterols and terpenoids were also present in the leaves of L. ovalifolia, however, flavonoids and alkaloids were absent (Table 1). Essiett et al. (2011) reported the presence of phytochemicals such as tannins, glycosides, saponins, flavonoids and alkaloids in the leaves of L. ovalifolia. The absence of flavonoids and alkaloids in the leaves of L. ovalifolia as observed in this study may be due to the different geographical location of the plant, the season and time of collection which are all contributing factors leading to variations in the phytochemical constituents of plants of the same species (Stackpole et al., 2011; González‐Martínez et al., 2006). In addition to the phytochemical screening, HLPC profile of the 70% methanol extracts (HLLE, and LOLE) were developed for identification purposes. HPLC profiling is more specific and helps in easy identification and confirmation of plant on the basis of specific phytochemicals present. The HPLC profiles of the extracts (Figures 1 and 2) showed that the peaks representing compounds present in the extracts appeared in the early part (early elution) of the chromatogram. This observation may be due to the polar solvent (70% methanol) used for the extraction. The profiles indicate the complex chemical composition of the extracts and provide identification parameters to figure out alterations in crude extracts (Tistaert et al., 2012). HLLE and LOLE exhibited a broad spectrum antibacterial activity against B. subtilis, S. aureus, E. feacalis, S. pyogenes, E. coli, S. typhi, K. pneumonia and P. aeruginosa with MIC ranging from 50 to 100 mg/ml (Table 2). The antibacterial activity observed may be attributed to the phytochemical constituents present in the extracts, since these phyto-constituents have been reported to exhibit antimicrobial properties (Edeoga et al., 2005; Nweze et al., 2004). The low antibacterial activity of HLLE and LOLE may be as a result of low amount of the active constituents 364 J. Med. Plants Res. UV1000-254nm Retention Time 7.227 20 4.395 1.017 20 mAU 40 1.235 1.362 1.408 1.662 2.0681.855 2.722 3.382 40 0 0 0 5 10 15 20 25 30 Minutes Figure 1. HPLC profile of methanol leaf extract of H. latifolia (HLLE) at λ 254 nm. UV1000-254nm Retention Time 1.997 7.5 5.0 2.5 2.5 0.0 mAU 5.0 1.063 1.475 2.342 3.111 7.5 0.0 0 5 10 15 20 25 30 Minutes Figure 2. HPLC profile of methanol leaf extract of L. ovalifolia (LOLE) at λ 254 nm. in the extracts. Similar to this observation, Okwulehie and Akanwa (2013) reported a low antimicrobial activity of L. ovalifolia. At MIC of 50 mg/ml, L. ovalifolia did not inhibit the growth of the test organisms. Also, Assob et al. (2011) reported on the antimicrobial activity of H. latifolia with MIC of 0.6 to 2.5 mg/ml. The high MIC (50 to 100 mg/ml) observed for H. latifolia in this study may be as a result of different extraction procedures used and different locality of the plant materials used which may lead to different composition in terms of primary and secondary metabolites. Even though, HLLE and LOLE may not be potential source of antimicrobial agents as reported by Navarro and Delgado (1999) and Fabry et al. (1998) because of their relatively high MICs, it is also well noted that plant extracts with low antimicrobial activity may have some phyto-constituents that can modify the antimicrobial activity of some existing antimicrobial agents, especially against resistant bacteria (Adu et al., 2009). Subinhibitory concentrations (5 mg/ml) of HLLE and LOLE modified the activity of amoxicillin, erythromycin, ciprofloxacin, tetracycline and ampicillin by either potentiating or reducing their activity against the test organisms. The increased activity of these antibiotics in the presence of the sub-inhibitory concentration of the extracts may be attributed to the phytochemicals present in the extracts. For instance, flavonoids have been reported to have the ability to reverse the resistance of S. aureus to some antibiotics (Aiyegoro et al., 2009). The Dapaah et al. 365 Table 3. Effect of sub-inhibitory concentration (5mg/mL) of HLLE and LOLE on activity of selected antibiotics against test organisms. Antibiotic only/Antibiotic + HLLE/ LOLE BS SA Test organisms EF SP EC ST Number of folds increase in activity 1 >0.25 8 2 1 >0.25 2 0.5 KP PA 1 0.5 2 1 Amx HLLE LOLE 4 1 8 2 Amp HLLE LOLE 1 0.25 1 1 1 1 >0.0625 >0.0625 2 1 4 0.25 1 0.5 1 >0.0625 Tet HLLE LOLE 1 0.125 1 0.25 1 0.25 1 0.25 0.5 0.125 1 0.25 4 0.5 2 0.5 Ery HLLE LOLE 0.25 0.5 0.0625 0.125 0.125 0.25 0.125 0.0625 0.0625 0.0625 0.0625 0.125 0.125 0.125 0.25 0.125 Cip HLLE LOLE 0.125 0.0625 0.5 0.125 0.5 0.25 0.5 0.25 0.125 0.125 0.25 0.125 0.5 0.125 0.25 0.125 EC: E. coli, BS: B. subtilis, ST: S. typhi, KP: K. pneumonia, SA: S. aureus, EF: E. feacalis, SP: S. pyogenes, PA: P. aeruginosa. Amx: amoxicillin, Amp: ampicillin, Tet: tetracycline, Ery: erythromycin, Cip: ciprofloxacin, HLLE: methanol leaf extract of Hilleria latifolia, LOLE: methanol leaf extract of Laportea ovalifolia. activity of the test antibiotics was enhanced mainly by HLLE as compared to LOLE. This may be as a result of the presence of flavonoids in HLLE and its absence in LOLE Antimicrobials from plants, at sub-inhibitory concen-trations, have been reported to be efficient in synergism with antibiotics by enhancing their antimicrobial actions (Kamatou et al., 2006). The phytochemicals act by reversing the resistance mechanisms of some microorganisms, thereby rendering them susceptible to previously inactive antibiotics (Tenover, 2006). Plants have also been known to produce multi-drug resistance inhibitors (MDRIs) to enhance the antimicrobial activities of compounds (Stermitz et al., 2000). The reduced or nullified activity of the antibiotics may be as a result of interactions between the phytochemicals in the extract and the antibiotics or the microorganisms. The phyto-constituents may react chemically with the antibiotics leading to loss of activity (Adu et al., 2009, 2014). It has been established that certain substances including plant constituents can shield microorganisms from the lethal effects of some antimicrobial agents (Keweloh et al., 1989). For example, some phytochemicals can bind to the surface structures of microorganisms thereby reducing their permeability to antibiotics (Adu et al., 2014). Furthermore, some of the phyto-contituents may act as protein activators or coenzymes which bind to and activate enzymes responsible for resistance in an organism, making them resistant to a previously potent antibiotic (Lambert, 2002). There is need to isolate the bioactive agents or compounds responsible for the antibiotic resistance modifying properties especially those that potentiated the activity of the extracts against resistant bacterial strains. Conclusion The sub-inhibitory concentrations of the methanol leaf extracts of H. latifolia and L. ovalifolia modified the activity of some antibiotics by either potentiating or reducing their antibacterial activities. Conflict of interests The authors have declare no conflict of interests. ACKNOWLEDGEMENTS The authors gratitude goes to Dr. Alex Asase and Mr. John Yaw Amponsah of Ghana Herbarium and Department of Botany, University of Ghana, Legon, Accra, Ghana for the identification and collection of the plant material. Also to Mr. Francis Amankwah, Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana, for his assistance during the study. REFERENCES Abotsi WKM, Ainooson GK, Woode E (2012). Anti-inflammatory and 366 J. Med. Plants Res. antioxidant effects of an ethanolic extract of the aerial parts of Hilleria latifolia (Lam.) H. Walt.(Phytolaccaceae). Afr. J. Tradit. Complement. Altern. Med. 9(1):138-52. Adu F, Gbedema S, Annan K (2009). Antimicrobial and Resistance Modulatory activities of Corynanthe pachyceras. Pharmacogn. Res. 1(5):280. Adu F, Sam GH, Agyare C, Apenteng JA, Boamah VE (2014). Influence of methanol fruit and leaf extracts of Myristica fragrans (Myristicaceae) on the activity of some antibiotics. Afr. J. Microbiol. Res. 8(19):1982-1986. Agyare C, Asase A, Lechtenberg M, Niehues M, Deters A (2009). An ethnopharmacological survey and in vitro confirmation of ethnopharmacological use of medicinal plants used for wound healing in Bosomtwi-Atwima-Kwanwoma area. Ghana J. Ethnopharmacol. 125(3):393-403. Agyare C, Koffuor GA, Boamah VE, Adu F, Mensah KB (2012). Antimicrobial and anti-inflammatory activities of Pterygota macrocarpa and Cola gigantea (Sterculiaceae). Evid-Based Complement. Altern. Med. 9p. Aiyegoro OA, Afolayan AJ, Okoh AI (2009). Synergistic interaction of Helichrysum pedunculatum leaf extracts with antibiotics against wound infection associated bacteria. Biol. Res. 42(3):327-38. Assob JCN, Kamga HLF, Nsagha DS, Njunda AL, Nde PF (2011). Antimicrobial and toxicological activities of five medicinal plant species from Cameroon Traditional Medicine. BMC Complement. Altern. Med. 11(1):70. Barbosa-Filho JM, Piuvezam MR, Moura MD, Silva MS, Lima KVB (2006). Anti-inflammatory activity of alkaloids: A twenty-century review. Rev. Bras. Farmacogn. 16(1):109-39. Bouch CH (2004). Laportea ovalifolia (Schumach.) Chew. Veg Grubben GJH. Dent AO.(eds) Porta Press London. Chew WL (1969). Monograph of Laportea (Urticaceae). Gard Bull. Coates A, Hu Y, Bax R, Page C (2002). The future challenges facing the development of new antimicrobial drugs. Nat. Rev. Drug Discov. 1(11):895-910. Dokosi OB (1998). Herbs of Ghana. Ghana Universities Press. Accra, Ghana. 746p. Edeoga HO, Okwu DE, Mbaebie BO (2005). Phytochemical constituents of some Nigerian medicinal plants. Afr. J. Biotechnol. 4(7):685-8. Eloff JN (1998). A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Med. 64(8):711-3. Essiett UA, Ede NI, Bala DN (2011). Phytochemical and physicochemical analysis of the leaves of Laportea aestuans (Linn.) Chew and Laportea ovalifolia (Schumach.) Chew (male and female). Asian J. Plant Sci. Res. 1(2):35-42. Fabry W, Okemo PO, Ansorg R (1998). Antibacterial activity of East African medicinal plants. J. Ethnopharmacol. 60(1):79-84. González‐Martínez SC, Krutovsky KV, Neale DB (2006). Forest‐tree population genomics and adaptive evolution. New Phytol. 170(2):22738. Gurib-Fakim A (2006). Medicinal plants: traditions of yesterday and drugs of tomorrow. Mol. Aspects Med. 27(1):1-93. Jenke-Kodama H, Müller R, Dittmann E (2008). Evolutionary mechanisms underlying secondary metabolite diversity. Natural Compounds Drugs, Springer 1:119-140. Kamatou GPP, Van Zyl RL, Van Vuuren SF, Viljoen AM, Cristina Figueiredo A (2006). Chemical composition. leaf trichome types and biological activities of the essential oils of four related Salvia species indigenous to southern Africa. J. Essent. Oil Res. 18:72-9. Keweloh H, Heipieper HJ, Rehm HJ (1989). Protection of bacteria against toxicity of phenol by immobilization in calcium alginate. Appl. Microbiol. Biotechnol. 31(4):383-389. Lambert PA (2002). Mechanisms of antibiotic resistance in Pseudomonas aeruginosa. J. R. Soc. Med. 95(Suppl 41):22-26. Levy SB (2005). Antibiotic resistance-the problem intensifies. Adv. Drug Deliv. Rev. 57(10):1446-1450. Levy SB, Marshall B (2004). Antibacterial resistance worldwide causes. challenges and responses. Nat. Med. 10:S122-9. Maganha EG, da Costa Halmenschlager R, Rosa RM, Henriques JAP, de Paula Ramos (2010). Pharmacological evidences for the extracts and secondary metabolites from plants of the genus Hibiscus. Food Chem. 118(1):1-10. Mbagwu HO, Anene RA, Adeyemi OO (2007). Analgesic, antipyretic and anti-inflammatory properties of Mezoneuron benthamianum Baill (Caesalpiniaceae). Nig. Q. J. Hosp. Med. 17(1):35-41. Mshana NR (2000). Traditional medicine and pharmacopoeia: contribution to the revision of ethnobotanical and floristic studies in Ghana. Organization of African Unity/Scientific. Technical & Research Commission. Nascimento GGF, Locatelli J, Freitas PC, Silva GL (2000). Antibacterial activity of plant extracts and phytochemicals on antibiotic-resistant bacteria. Braz. J. Microbiol. 31(4):247-56. Navarro V, Delgado G (1999). Two antimicrobial alkaloids from Bocconia arborea. J. Ethnopharmacol. 66(2):223-6. Nweze EI, Okafor JI. Njoku O (2004). Antimicrobial activities of methanolic extracts of Trema guniesnsis (Schum and Thom) and Morinda lucida Benth. used in Nigerian Herbal Medical Practices. J. Biol. Res. Biotechnol. 2(1):39-46. Okwulehie IC, Akanwa FE (2013). Antimicrobial Activity of ethanol extract of four indigenous plants from South Eastern Nigeria. ARPN J. Sci. Technol. 3(4):350-355. Oluwatuyi M, Kaatz GW, Gibbons S (2004). Antibacterial and resistance modifying activity of Rosmarinus officinalis. Phytochemistry 65(24):3249-3254. Projan SJ (2003). Why is big Pharma getting out of antibacterial drug discovery? Curr. Opin. Microbiol. 6(5):427-430. Ranjan S, Bhavya K, Muntaj S, Basumata G, Matcha R (2012). Synergistic effect of some medicinal plants and antibiotics against few pathogenic bacteria. Int. J. Biol. Pharm. Res. 3(8):1000-1004. Rios JL, Recio MC (2005). Medicinal plants and antimicrobial activity. J. Ethnopharmacol. 100(1):80-84. Schmelzer GH, Gurib-Fakim A (2008). Plant Resources of Tropical Africa 11 (1). Medicinal Plants 1. PROTA Foundation. Wageningen. Netherlands. Backhuys Publishers. Leiden. Netherlands/CTA. Wageningen. Netherlands. Sibanda T, Okoh AI (2007). The challenges of overcoming antibiotic resistance: Plant extracts as potential sources of antimicrobial and resistance modifying agents. Afr. J. Biotechnol. 6(25):2886-2896. Sofowora A (1993). Recent trends in research into African medicinal plants. J. Ethnopharmacol. 38(2):197-208. Sofowora A (1996). Research on medicinal plants and traditional medicine in Africa. J. Altern. Complement Med. 2(3):365-372. Stackpole DJ, Vaillancourt RE, Alves A Rodrigues J, Potts BM (2011). Genetic variation in the chemical components of Eucalyptus globulus wood. G3 (Bethesda) 1(2):151-9. Stermitz FR, Tawara-Matsuda J, Lorenz P, Mueller P, Zenewicz L (2000). 5’-Methoxyhydnocarpin-D and Pheophorbide A: Berberis species components that potentiate berberine growth inhibition of resistant Staphylococcus a ureus. J. Nat. Prod. 63(8):1146-1149. Tenover FC (2006). Mechanisms of antimicrobial resistance in bacteria. Am. J. Med. 119(6):S3-10. Tistaert C, Dejaegher B, Chataigné G, Rivière C, Hoai NN (2012). Potential antioxidant compounds in Mallotus species fingerprints. Part II: fingerprint alignment, data analysis and peak identification. Anal. Chim. Acta 721:35-43. Trease GE, Evans WC (2002). Pharmacognosy. Saunders. Elsevier. Amsterdam. The Netherlands. 36:51. Usman JG, Sodipo OA, Sandabe UK (2014). Phytochemical screening and acute toxicity study of Cucumis metuliferus E. Mey. Ex. Naudin fruit extract in cockerels. Int. J. Phytomed. 6(2):243.